Market
DMT therapy for alcohol misuse approved in any EU country by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official regulatory announcements from EU member countries
Story
UCL to Trial Dimethyltryptamine (DMT) on UK Volunteers to Combat Alcohol Misuse
Jan 19, 2025, 12:45 PM
Scientists at University College London (UCL) are set to trial the psychedelic drug dimethyltryptamine (DMT) on UK volunteers in an effort to address alcohol misuse. The study aims to determine whether a single dose of this powerful hallucinogen can assist individuals in reducing their alcohol intake. DMT, known for its use in traditional healing ceremonies, has garnered interest as a potential therapeutic agent in treating substance dependence. This initiative aligns with broader discussions in the European Union regarding the regulation and funding of psychedelic therapies, as various organizations advocate for equitable access to such treatments across member states.
View original story
Similar markets
United Kingdom • 25%
United States • 25%
Canada • 25%
Australia • 25%
Yes • 50%
No • 50%
Switzerland • 25%
Other • 25%
France • 25%
Germany • 25%
Depression • 25%
Anxiety • 25%
PTSD • 25%
Addiction • 25%
Effective only for alcohol use disorder • 25%
Not effective for either condition • 25%
Effective for both PTSD and alcohol use disorder • 25%
Effective only for PTSD • 25%
Yes • 50%
No • 50%
Same level of funding • 25%
Decreased funding • 25%
No funding • 25%
Increased funding • 25%